Healthcare - Biotechnology - NYSE - US
$ 2.63
-8.36 %
$ 885 M
Market Cap
-1.21
P/E
INCOME STATEMENT
0
REVENUE
-99.8 M
OPERATING INCOME
-75.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Nuvation Bio Inc.
| Revenue | 0 |
| Cost Of Revenue | 222 K |
| Gross Profit | -222 K |
| Operating Expenses | 99.8 M |
| Operating Income | -99.8 M |
| Other Expenses | -24 M |
| Net Income | -75.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.2 | 0.5 | 0.4 | 0.1 | 0 | 0 |
| Gross Profit | (0.2) | (0.5) | (0.4) | (0.1) | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 99.8 | 119.7 | 93.3 | 43.6 | 32.2 | 1.0 |
| Selling, General and Administrative Expenses | 28.5 | 31.9 | 24.3 | 10.9 | 7.0 | 0.5 |
| Research and Development Expenses | 71.3 | 87.8 | 69.0 | 32.6 | 25.1 | 0.5 |
| Operating Income | (99.8) | (119.7) | (93.3) | (43.6) | (32.1) | (1.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | (9.2) | 0 | 0 | 0 | 0 |
| Total Other Income | 24.0 | 15.5 | 6.5 | 1.9 | (1.5) | 0 |
| Pre-Tax Income | (75.8) | (104.2) | (86.8) | (41.7) | (33.6) | (1.0) |
| NET INCOME | ||||||
| Tax Provision | 0 | (15.5) | (7.1) | (2.2) | 0 | 0 |
| Net Income | (75.8) | (88.7) | (79.7) | (39.5) | (33.6) | (1.0) |
| EPS | 0.35 | 0.41 | 0.4 | 0.4 | 0.16 | 0.0122 |